Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06570408
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
Precision Application of Clostridium Butyricm of Clinical Research on Osteoarthritis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Precision Application of Clostridium Butyricm of Clinical Research on Osteoarthritis
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Osteoarthritis OA is a common joint disease worldwide The main symptom is that the mechanical wear of the cartilage in the joint and leads to the abnormal proliferation of the surrounding bone and synovial tissue with the chronic inflammation and the narrowing of the joint cavity The prevalence of OA is increasing due to population increasing and aging and there are currently about 400 million OA patients in worldwide The treatment methods of osteoarthritis are mainly divided into medicine and non-medicine therapy The major function of medicine therapy is to reduce pain and the arthroscopic surgery arthroscopy is main treatment of non-medicine therapy Thus in this project the investigators will mainly focus on the precise application of Clostridium butyricum on OA and the investigators previous study successfully demonstrated the therapeutic effects of Clostridium butyricum on OA animal model Therefore will test the clinical effects of OA patient with Clostridium butyricum treatment and whether it is also possible to improve the symptom of OA patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None